NCT04417049View on ClinicalTrials.gov

Treatment of Bipolar Depression With Pentoxifylline

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 12, 2021

Primary Completion Date

November 3, 2021

Study Completion Date

November 29, 2021

Conditions
Bipolar Depression
Interventions
DRUG

Pentoxifylline 400 MG

All patients will be provided with pentoxifylline 400 mg to be orally ingested twice daily for 8 weeks.

Trial Locations (1)

M5T 2S8

Toronto Western Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER